3RYDER NS,FAVRE B. Antifungal activity and mechanism of action of tetbinafine [ J]. Rev Contemp Pharmcother,1997,8:275 -287.
4Ghannoum MA, Elewski B. Successful treatment of fluconazole - resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine. Clin Diagn Lab Immunol 1999 ; 6 (6) : 921 - 923.
5Michael Weig, Frank - Michael C. Synergism of voriconazole and terbinafine against eandida albieans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 2001 ;45(3) :966 - 968.
6National Conunittee for Clinical Laboratory standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27 - A. National Committee for Clinical Laboratory standards Wayne Pa. NCCLS 1997 ; 17(9) : 1.
7Mosquera J, Sharp A, Moore CB, et al. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp. J Antimicrob Chemother 2002; 50(2) : 189.
8杨国亮 王侠生.现代皮肤病学[M].上海：上海医科大学出版社,1998.763.
9Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS:documentation by in vitro susceptibility testing and DNA subtype analysis[J]. Clin Infect Dis, 1994,
10White TC,Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient[J]. Oral Dis, 1997,3(suppl 1) : 102- 109.
